merck oral glp-1 Enters Exclusive Alliance with Hansoh Pharma for Candidate Lilly's GLP-1 pill tops Novo's
Description
Payer contracting plays a key role in this market as brands compete for preferred formulary placement
At least not from Vital Proteins
Where tirzepatide differs is in the breadth of documented side effects from its longer time on market and larger real-world patient population
Your provider will set clear expectations based on your unique response and goals
